Phenotypic correlations in FTDP-17

Neurobiology of Aging

Volumn 22, Issue 1, 2001, Pages 89-107

  Reed, Lee A ^a   Wszolek, Zbigniew K ^b   Hutton, Mike ^b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Alternative splicing; Frontotemporal dementia; FTDP 17; Hereditary neurodegenerative disease; Parkinsonism; Tau

Indexed keywords

AMINO ACID; ISOPROTEIN; TAU PROTEIN;

ALTERNATIVE RNA SPLICING; ALZHEIMER DISEASE; BINDING SITE; CHROMOSOME 17; CLINICAL FEATURE; CORTICOBASAL DEGENERATION; DELETION MUTANT; DISEASE PREDISPOSITION; DISEASE SEVERITY; EXON; FRONTOTEMPORAL DEMENTIA; GENETIC CODE; HUMAN; INTRON; MICROTUBULE; MISSENSE MUTATION; NEUROFIBRILLARY TANGLE; PARKINSONISM; PHENOTYPE; PICK PRESENILE DEMENTIA; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; REVIEW;

EID: 0035063421     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-4580(00)00202-5     Document Type: Note

References (105)

1. Ubiquitin, cellular inclusions and their role in neurodegeneration
2. A tau promoter region without neuronal specificity
3. The tau mutation (val337 met) disrupts cytoskeletal networks of microtubules
4. Two brothers with frontotemporal dementia and parkinsonism with an N279K mutation of the tau gene
5. Polymerization of tau peptides into fibrillar structures. The effect of FTDP-17 mutations
6. Localization of frontotemporal dementia with parkinsonism in an Australian kindred to chromosome 17q21-22
7. Association of an extended haplotype in the tau gene with progressive supranuclear palsy
8. Genotypes, phenotypes, and frontotemporal dementia: Take your pick
9. A clinical pathological comparison of three families with frontotemporal dementia and identical mutations in the tau gene (P301L)
10. Chromosome 17 and hereditary dementia: Linkage studies in three non- Alzheimer families and kindreds with late-onset FAD
11. Tau-mediated process outgrowth is differentially altered by the expression of MAP2b and MAP2c in Sf9 cells
12. Clinical and neuropathological criteria for frontotemporal dementia
13. Frontotemporal dementia and corticobasal degeneration in a family with a P301S mutation in tau
14. The association of tau-like proteins with vimentin filaments in cultured cells
15. Overexpression of four-repeat tau mRNA isoforms in progressive supranuclear palsy but not in Alzheimer's disease
16. Pathogenic implications of mutations in the tau gene in pallido-ponto- nigral degeneration and related neurodegenerative disorders linked to chromosome 17
17. Differences in a dinucleotide repeat polymorphism in the tau gene between Caucasian and Japanese populations: Implication for progressive supranuclear palsy
18. A family with autosomal dominant, non-Alzheimer's presenile dementia
19. Mutations in tau reduce its microtubule binding properties in intact cells and affect its phosphorylation
20. A mutation at codon 279 (N279K) in exon 10 of the Tau gene causes a tauopathy with dementia and supranuclear palsy
21. Missense tau mutations identified in FTDP-17 have a small effect on tau- microtubule interactions
22. Missense and silent tau gene mutations cause frontotemporal dementia with parkinsonism-chromosome 17 type, by affecting multiple alternative RNA splicing regulatory elements
23. Segregation of a missense mutation in the microtubule-associated protein tau gene with familial frontotemporal dementia and parkinsonism
24. Neuropathologic overlap of progressive supranuclear palsy, Pick's disease and corticobasal degeneration
25. Frontotemporal dementia and parkinsonism linked to chromosome 17: A consensus conference
26. Abnormal microtubule packing in processes of SF9 cells expressing the FTDP-17 V337M tau mutation
27. Complex regulation of tau exon 10, whose missplicing causes frontotemporal dementia
28. The apolipoprotein E epsilon4 allele is not a significant risk factor for frontotemporal dementia
29. Neurofibrillary pathology of Alzheimer's disease and other tauopathies
30. Tau mutations cause frontotemporal dementias
31. Effects of frontotemporal dementia FTDP-17 mutations on heparin-induced assembly of tau filaments
32. Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulphated glycosaminoglycans
33. Tau gene mutation in familial progressive subcortical gliosis
34. Cloning and sequencing of the cDNA encoding an isoform of microtubule- associated protein tau containing four tandem repeats: Differential expression of tau protein mRNAs in human brain
35. Identification of a novel microtubule binding and assembly domain in the developmentally regulated inter-repeat region of tau
36. Hereditary Pick's disease: Second re-examination of the large family and discussion of other hereditary cases, with particular reference to electroencephalography, a computerized tomography
37. 5′ splice site mutations in tau associated with the inherited dementia FTDP-17 affect a stem-loop structure that regulates alternative splicing of exon 10
38. Altered microtubule organization in small-calibre axons of mice lacking tau protein
39. Pathways to primary neurodegnerative disease
40. Genetic dissection of Alzheimer's disease and related dementias: Amyloid and its relationship to tau
41. Genetic classification of primary neurodegenerative disease
42. Tau proteins with FTDP-17 mutations have a reduced ability to promote microtubule assembly
43. FTDP-17 mutations N279K and S305N in tau produce increased splicing of exon 10
44. Hereditary frontotemporal dementia is linked to chromosome 17q21-q22; a genetic and clinicopathologic study of three Dutch families
45. Progressive supranuclear gaze palsy is in linkage disequilibrium with the tau and not the alpha-synuclein gene
46. Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17
47. Frequency of tau mutations in three series of non-alzheimer's degenerative dementia
48. Apolipoprotein E genotype does not affect the age of onset of dementia in families with defined tau mutations
49. Neuropathological features of frontotemporal dementia and parkinsonism linked to chromosome 17q21-22 (FTDP-17): Duke Family 1684
50. Missense and splicing mutations in tau associated with FTDP-17: Multiple pathogenic mechanisms
51. "Missing" tau mutation identified
52. Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
53. A distinct familial presenile dementia with a novel missense mutation in the tau gene
54. A subset of senile dementia with high incidence of the apolipoprotein E epsilon2 allele
55. Muscle weakness, hyperactivity, and impairment in fear conditioning in tau-deficient mice
56. Pallidonigroluysian degeneration with iron deposition: A study of three autopsy cases
57. Dementia lacking distinctive histologic features: A common non- Alzheimer degenerative dementia
58. Ultrastructure and biochemical composition of paired helical filaments in corticobasal degeneration
59. Familial progressive subcortical gliosis
60. Exploring the etiology of Alzheimer disease using molecular genetics
61. Hereditary dysphasic disinhibition dementia: A frontotemporal dementia linked to 17q21-22
62. Clinical and genetic aspects of progressive supranuclear palsy
63. Clinical characteristics of a family with chromosome 17-linked disinhibition-dementia-parkinsonism-amyotrophy complex
64. Dementia of frontal type and dementias with subcortical gliosis
65. Stable expression in Chinese hamster ovary cells of mutated tau genes causing frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17)
66. Tau pathology in a family with dementia and a P301L mutation in tau
67. Mutation in the tau exon 10 splice site region in familial frontotemporal dementia
68. Familial multiple-system tauopathy with presenile dementia is localized to chromosome 17
69. Tau gene mutation G389R causes a tauopathy with abundant pick body-like inclusions and axonal deposits
70. Accelerated filament formation from tau protein with specific FTDP-17 missense mutations
71. From genotype to phenotype: A clinical pathological, and biochemical investigation of frontotemporal dementia and parkinsonism (FTDP-17) caused by the P301L tau mutation
72. Identification of cDNA clones for the huma microtubule-associated protein tau and chromosomal localization of the genes for tau and microtubule-associated protein 2
73. Familial progressive subcortical gliosis: Presence of prions and linkage to chromosome 17
74. Tau is a candidate gene for chromosome 17 frontotemporal dementia
75. Autosomal dominant dementia with widespread neurofibrillary tangles
76. The neuropathology of a chromosome 17-linked autosomal dominant parkinsonism and dementia ("pallido-ponto-nigral degeneration")
77. High prevalence of mutations in the microtubule-associated protein tau in a population study of frontotemporal dementia in the Netherlands
78. Identification of a tau promoter region mediating tissue-specific-regulated expression in PC12 cells
79. Re-examination of a family with Pick's disease
80. Convergence of Lewy bodies and neurofibrillary tangles in amygdala neurons of Alzheimer's disease and Lewy body disorders
81. The neuropathology of chromosome 17-linked dementia
82. Molecular Interactions among Protein Phosphatase 2A, Tau, and Microtubules. Implications for the regulation of tau phosphorylation and the development of tauopathies
83. FTDP-17: An early-onset phenotype with parkinsonism and epileptic seizures caused by a novel mutation
84. Mutation in the tau gene in familial multisystem tauopathy with presenile dementia
85. Frontotemporal dementia and Parkinsonism linked to chromosome 17: A new group of tauopathies
86. Comparison of the neurofibrillary pathology in Alzheimer's disease and familial presenile dementia with tangles
87. Tau pathology in two Dutch families with mutations in the microtubule- binding region of tau
88. Familial multiple system tauopathy with presenile dementia: A disease with abundant neuronal and glial tau filaments
89. Progressive supranuclear palsy pathology caused by a novel silent mutation in exon 10 of the tau gene: Expansion of the disease phenotype caused by tau gene mutations
90. Familial presenile dementia with psychosis associated with cortical neurofibrillary tangles and degeneration of the amygdala
91. Phenotypic variation in hereditary frontotemporal dementia with tau mutations
92. Structure of tau exon 10 splicing regulatory element RNA and destabilization by mutations of frontotemporal dementia and parkinsonism linked to chromosome 17
93. Structural basis for recognition of the RNA major groove in the tau exon 10 splicing regulatory element by aminoglycoside antibiotics
94. Localization of the gene for rapidly progressive autosomal dominant parkinsonism and dementia with pallido-ponto-nigral degeneration to chromosome 17q21
95. Disinhibition-dementia-parkinsonism-amyotrophy complex (DDPAC) is a non-Alzheimer's frontotemporal dementia
96. Localization of disinhibition-dementia-parkinsonism-amyotrophy complex to 17q21-22
97. Rapidly progressive autosomal dominant parkinsonism and dementia with pallido-ponto-nigral degeneration (PPND) and Disinhibition-dementia-parkinsonism-amyotrophy complex 9DDPAC) are clinically distinct conditions that are both linked to 17q21-22
98. Rapidly progressive autosomal dominant parkinsonism and dementia with pallido-ponto-nigral degeneration
99. Histological and biochemical pathology in a family with autosomal dominant parkinsonism and dementia
100. Linkage of frontotemporal dementia to chromosome 17: Clinical and neuropathological characterization of phenotype
101. A mutation in the microtubule-associated protein tau in pallido-nigro-luysian degeneration
102. A novel mutation at postion +12 in the intron following exon 10 of the tau gene in familial frontotemporal dementia (FTD-Kumamoto)
103. FTDP-17 tau mutations decrease the susceptibility of tau to calpain I digestion
104. Frontotemporal dementia: Neuropil spheroids and presynaptic terminal degeneration